Head-to-Head lupus drug study aims to find better treatment
Disease control
Not yet recruiting
This study will compare two existing medications for systemic lupus erythematosus (SLE) to see which works better and is safer. Researchers will observe 180 adults with moderate-to-severe lupus who choose either telitacicept or belimumab alongside their current treatments. The st…
Sponsor: Yipeng Liu • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC